Almirall Stock

Almirall Dividend

The Dividend of Almirall (ALM.MC) as of Aug 21, 2026 is 0.18 EUR. In the previous year, Dividend was 0.16 EUR — a change of 15.76% (higher).

Dividend

0.18EUR

YoY

15.76%

Dividend yield

1.77 %

Last updated:

How much dividend does Almirall 2026 pay?

According to the latest status from August 2026, Almirall paid a total of 0.18 EUR per share in dividends within the last 12 months. With the current Almirall price of 10.42 EUR, this corresponds to a dividend yield of 1.75 %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 1.77%. The payout ratio is around 85% of earnings.

Historical Almirall Dividends

A dividend is paid times per year. Last year, the payout months were and June.

PaydateDividend
6/15/20250.18EUR
6/17/20240.18EUR
6/12/20230.18EUR
6/13/20220.19EUR
6/14/20210.19EUR
10/14/20200.20EUR
6/15/20190.20EUR
6/16/20180.18EUR
6/30/20170.19EUR
6/27/20160.19EUR
7/1/20150.20EUR
6/17/20130.15EUR
6/15/20120.17EUR
7/1/20110.29EUR
7/1/20100.33EUR
7/1/20090.32EUR
6/23/20080.32EUR

Almirall dividend history and estimates

In 2025, Almirall paid a dividend amounting to 0.18 EUR. Dividend means that Almirall distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
0.19 EUR
0.00 EUR
Jan 1, 2022
0.19 EUR
0.00 EUR
Jan 1, 2023
0.18 EUR
0.00 EUR
Jan 1, 2024
0.18 EUR
0.00 EUR
Jan 1, 2025
0.18 EUR
0.00 EUR
Jan 1, 2026 (e)
0.00 EUR
0.18 EUR
Jan 1, 2027 (e)
0.00 EUR
0.18 EUR
Jan 1, 2028 (e)
0.00 EUR
0.18 EUR

Is the Almirall Dividend Safe?

Almirall has been increasing the dividend for 0 years.

Over the past 10 years, Almirall has lowered it by an annual -0.83%.

Over a five-year period, the distribution dropped by -1.46%.

Analysts expect a Dividend Increase of 0.00% for the current fiscal year.

Almirall dividend payout ratio

In 2025, Almirall had a payout ratio of 85.50%. The payout ratio indicates the percentage of the company's profits that Almirall distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
-80.62 %
Jan 1, 2022
772.55 %
Jan 1, 2023
-100.14 %
Jan 1, 2024
334.40 %
Jan 1, 2025
85.50 %
Jan 1, 2026 (e)
46.36 %
Jan 1, 2027 (e)
33.52 %
Jan 1, 2028 (e)
26.37 %

Dividend Details

Understanding Almirall's Dividend Distributions

Almirall’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Almirall's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Almirall's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Almirall’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Almirall Stock analysis

What does Almirall do? The company Almirall SA is a globally operating pharmaceutical company headquartered in Barcelona, Spain. Founded in 1943 by Antonio Gallardo Ballart, the company has since become one of the leading companies in the field of dermatology and respiratory diseases. Almirall specializes in the development, manufacturing, and marketing of medications used in the treatment of skin conditions such as psoriasis or eczema, as well as respiratory diseases such as asthma or chronic bronchitis. The company focuses on close collaboration with doctors and patients to achieve the best possible therapeutic success. Almirall's business model is based on collaboration with other pharmaceutical companies to develop and bring innovative medications to the market. The company has its own research and development departments and also conducts clinical trials to test the safety and efficacy of new medications. Additionally, Almirall operates its own network of distribution and marketing partners to distribute its products worldwide. Almirall is organized into three divisions: dermatology, respiratory diseases, and other therapeutic areas. The dermatology division includes the development and marketing of medications for the treatment of skin conditions such as psoriasis and eczema. Some examples of products in this division are Skilarence, a medication for the treatment of moderate to severe psoriasis, and Kigozi, a topical medication for the treatment of atopic dermatitis. The respiratory diseases division includes the development and marketing of medications for the treatment of asthma and chronic bronchitis. The company offers a wide range of medications in this area that can be used in inhalation or tablet therapy. Some of the well-known products in this division are Alvesco, an inhaled corticosteroid for the treatment of asthma, and Ebastel, a medication for the treatment of allergic reactions. In other therapeutic areas, Almirall is involved in the development of new medications for the treatment of diseases such as ulcerative colitis or schizophrenia. For example, the company has developed Sativex, a cannabis-based medication for the treatment of multiple sclerosis-related spasticity, which is already approved in several countries. Throughout its history, Almirall has received numerous awards and recognition, including for the development of innovative medications and its work in the field of sustainability and corporate social responsibility. Through its commitment to research and development and collaboration with other pharmaceutical companies, Almirall will continue to play an important role in the global pharmaceutical industry market. Almirall is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Almirall stock

Over the past 12 months, Almirall paid a dividend of 0.18 EUR . This corresponds to a dividend yield of about 1.77 %. For the coming 12 months, Almirall is expected to pay a dividend of 0.18 EUR.

The current dividend yield of Almirall is 1.77 %.

Almirall pays a dividend, distributed in the months of , , , .

Almirall paid dividends every year for the past 11 years.

For the upcoming 12 months, dividends amounting to 0.18 EUR are expected. This corresponds to a dividend yield of 1.75 %.

Almirall is assigned to the 'Health' sector.

To receive the latest dividend of Almirall from amounting to 0.18 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Almirall distributed 0.18 EUR as dividends.

The dividends of Almirall are distributed in EUR.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — Almirall